Alexza

Alexza rockets 30% on FDA update
Marketwatch
Fri, 06/22/12 - 04:00 pm
Alexza
FDA
bipolar disorder
Adasuve
FDA declines to approve Alexza's schizophrenia drug
Reuters
Fri, 05/4/12 - 10:42 am
schizophrenia
FDA
Alexza
Adasuve
Will the FDA Approve Alexza's Adasuve?
Motley Fool
Thu, 05/3/12 - 04:49 pm
FDA
Alexza
Adasuve
antipsychotics
Pfizer
Bristol-Myers Squibb
Eli Lilly
4 Healthcare Stocks Breaking Out Mid-Week
Seeking Alpha
Thu, 05/3/12 - 10:18 am
Dendreon
Alexza
TrovaGene
Amarin
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Mon, 04/30/12 - 10:12 pm
Pfizer
Arena Pharmaceuticals
Gilead Sciences
Vyndaqel
JNJ
Xarelto
ASCO
Talon Therapeutics
Marqibo
Quad
Truvada
lorcaserin
Protalix BioTherapeutics
Alexza
Adasuve
Arcalyst
Regeneron
Abbott Laboratories
Remicade
Pivotal FDA Decision Upcoming For Alexza
Seeking Alpha
Thu, 04/12/12 - 11:37 am
FDA
Alexza
Adasuve
schizophrenia
bipolar disorder
6 Biotech Stocks With Huge Potential In May
Seeking Alpha
Wed, 04/11/12 - 10:56 am
taliglucerase alfa
Protalix BioTherapeutics
Alexza
Adasuve
Regeneron
Arcalyst
lorcaserin
Arena Pharmaceuticals
Quad
Truvada
Gilead
Talon Therapeutics
Marqibo
Alexza Prices $22 Million Public Offering
Yahoo
Fri, 02/17/12 - 09:03 am
Alexza
stock offering
FDA extends review of Alexza product, shares fall
Reuters
Mon, 01/23/12 - 11:03 am
FDA
Alexza
Adasuve
antipsychotics
Alexza And Somaxon: 2 Distressed Biotechs On Sale And Up For Sale
Seeking Alpha
Tue, 12/20/11 - 10:51 am
Somaxon
Alexza
Alexza Pharmaceuticals: Forward Looking Approval Catalyst In Play
Seeking Alpha
Wed, 12/14/11 - 04:26 pm
Alexza
Adasuve
antipsychotics
Alexza Wins Panel’s Backing for Inhaled Antipsychotic Drug
Bloomberg
Mon, 12/12/11 - 10:49 pm
Alexza
FDA
advisory panels
antipsychotics
Adasuve
Hot Stock: Alexza Pharmaceuticals, Shares Gain 9.6% (ALXA)
Financial News Network
Sat, 12/10/11 - 01:05 pm
Alexza
Alexza Inhaled Antipsychotic May Pose Fatal Lung Risks, FDA Review Finds
Bloomberg
Thu, 12/8/11 - 11:22 am
Alexza
antipsychotics
FDA
Adasuve
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Alexza posts Q2 earnings, stock closes down 8%
Bizjournals.com
Tue, 08/9/11 - 10:03 am
Alexza
earnings
Alexza to raise $16.1M in direct offering
Bizjournals.com
Tue, 05/3/11 - 11:26 am
Alexza
stock offering
Biotech Stock Mailbag: Avanir Pharma
TheStreet.com
Fri, 04/1/11 - 10:08 am
Avanir
Alexza
Somaxon
Pharmasset
Radient Pharmaceuticals
RXi Pharmaceuticals
All Eyes on Alexza as Company Prepares to Re-File Drug Application
Seeking Alpha
Wed, 03/16/11 - 04:43 pm
Alexza
bipolar disorder
schizophrenia
AZ-004
Staccato Loxapine
Alexza shares tumble on FDA setback
Marketwatch
Tue, 01/18/11 - 11:21 am
Alexza
FDA
AZ-004
bipolar disorder
schizophrenia

Pages